Post-COVID-19 Myoclonus-Ataxia Syndrome Responsive to Intravenous Immunoglobulins

Overview

Journal Mov Disord Clin Pract

Publisher Wiley

Specialty Neurology

Date 2022 Sep 19

PMID 36118515

Authors

Massimiliano Godani

Alessandro Beronio

Giuseppe Lanza

Affiliations

Soon will be listed here.

Citing Articles

COVID-19 and Mental Health: A "Pandemic Within a Pandemic".

Fisicaro F, Lanza G, Concerto C, Rodolico A, Di Napoli M, Mansueto G Adv Exp Med Biol. 2024; 1458:1-18.

PMID: 39102186 DOI: 10.1007/978-3-031-61943-4_1.

A case of suspected autoimmune encephalopathy with involuntary movements and cognitive dysfunction post-COVID-19.

Tenpaku Y, Mabuchi N, Kawase T, Oguro H, Tatsumi H, Satoh M PCN Rep. 2024; 3(3):e224.

PMID: 39015732 PMC: 11249827. DOI: 10.1002/pcn5.224.

De Novo Movement Disorders Associated with COVID-19- A Systematic Review of Individual Patients.

Pillai K, Misra S, Siripurapu G, Aliyar A, Bhat P, Rajan R Ann Indian Acad Neurol. 2023; 26(5):702-707.

PMID: 38022478 PMC: 10666879. DOI: 10.4103/aian.aian_572_23.

Retrospective analysis of COVID-19 patients with Guillain-Barre, Miller-Fisher, and opsoclonus-myoclonus-ataxia syndromes-a case series.

Olbert E, Alhani N, Struhal W Wien Med Wochenschr. 2023; 174(1-2):30-34.

PMID: 37523107 PMC: 10810910. DOI: 10.1007/s10354-023-01018-4.

Post-COVID-19 Myoclonus-Ataxia Syndrome-Is there Really a Need for Intravenous Immunoglobulin Treatment in all Cases?.

Przytula F, Slawek J Mov Disord Clin Pract. 2023; 10(4):724-725.

PMID: 37070049 PMC: 10105119. DOI: 10.1002/mdc3.13695.

References

Schellekens M, Bleeker-Rovers C, Keurlings P, Mummery C, Bloem B . Reversible Myoclonus-Ataxia as a Postinfectious Manifestation of COVID-19. Mov Disord Clin Pract. 2020; 7(8):977-979. PMC: 7604679. DOI: 10.1002/mdc3.13088. View

Shah P, Desai S . Opsoclonus Myoclonus Ataxia Syndrome in the Setting of COVID-19 Infection. Neurology. 2020; 96(1):33. DOI: 10.1212/WNL.0000000000010978. View

Chan J, Murphy K, Sarna J . Myoclonus and cerebellar ataxia associated with COVID-19: a case report and systematic review. J Neurol. 2021; 268(10):3517-3548. PMC: 7897737. DOI: 10.1007/s00415-021-10458-0. View

Pennisi M, Lanza G, Falzone L, Fisicaro F, Ferri R, Bella R . SARS-CoV-2 and the Nervous System: From Clinical Features to Molecular Mechanisms. Int J Mol Sci. 2020; 21(15). PMC: 7432482. DOI: 10.3390/ijms21155475. View

Fisicaro F, Di Napoli M, Liberto A, Fanella M, Di Stasio F, Pennisi M . Neurological Sequelae in Patients with COVID-19: A Histopathological Perspective. Int J Environ Res Public Health. 2021; 18(4). PMC: 7913756. DOI: 10.3390/ijerph18041415. View